Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 3,207

Document Document Title
WO2005014515A3
The present invention relates to clear photopolymerisable systems for the preparation of high thickness coatings, to a procedure for their application and to the solid surfaces coated with them.  
WO/2005/037810A2
The invention relates to a compound of formula (I), wherein n ranges from 1 to 6, A is aryl such as phenyl or naphtyle, or monocyclic heteroaryl such as thienyl, furyl or pyrrolyl; aryl or heteroaryl being substituted, if necessary; B is...  
WO2005014525A3
The invention is directed to a bi-aryl compound having a unique immunomodulating activity, a process for a preparation thereof, a pharmaceutical composition containing the same, and a method of preventing or treating disorders or disease...  
WO1999002124A3
The invention provides compositions and methods for the direct dyeing of keratinous fibers, with particular regard to human hair on the head. The compositions of the invention contain novel anthraquinone mixtures in which each of the com...  
WO/2005/027157A2
A salt fusible at ordinary temperature which comprises: a cation ingredient obtained by introducing a cationic group into a volatile organic solvent; and an anion ingredient selected from the group consisting of an inorganic ion, sulfoni...  
WO2004087061A3
A diverse set of tubulin binding agents have been discovered which are structurally characterized, in a general sense, by a semi-rigid molecular framework capable of maintaining aryl-aryl, pseudo pi stacking distances appropriate for mol...  
WO2004073642A3
The present invention provides a combinatorial approach to a library of novel compounds having four diversity points. The compounds provide for the mapping of urotensin II and somatostatin 5 receptors by differential binding of said rece...  
WO2004112690A3
The invention relates to 2-aminobenzoyl-alkylamines, -alkylamides and - alkylthioamides, and their application for treatment or prevention of various physiological conditions.  
WO2005000795A3
This invention relates to aniline derived non-steroidal compounds that are or are believed to be modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of suc...  
WO/2005/014515A2
The present invention relates to clear photopolymerisable systems for the preparation of high thickness coatings, to a procedure for their application and to the solid surfaces coated with them.  
WO/2005/014525A2
The invention is directed to a bi-aryl compound having a unique immunomodulating activity, a process for a preparation thereof, a pharmaceutical composition containing the same, and a method of preventing or treating disorders or disease...  
WO/2005/012228A1
The invention relates to novel o ptical recording materials that comprise specific and in some cases novel diketone enamines or metal chelates thereof and that have excellent recording and playback quality especially ata wavelength of 35...  
WO/2005/009940A1
The invention provides novel compounds according to formula I relates to compounds with the general formula I said compounds being useful, e.g. in the treatment of inflammatory, ophthalmic diseases or cancer.  
WO/2005/000795A2
This invention relates to aniline derived non-steroidal compounds that are or are believed to be modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of suc...  
WO/2004/112690A2
The invention relates to 2-aminobenzoyl-alkylamines, -alkylamides and - alkylthioamides, and their application for treatment or prevention of various physiological conditions.  
WO/2004/108680A1
[PROBLEMS] To provide an industrially advantageous process for the production of important mother-nucleus intermediates of antibacterial agents and intermediates for the production thereof. [MEANS FOR SOLVING PROBLEMS] A process for the ...  
WO/2004/099262A1
The Invention relates to novel ketones of formulae (I) and (II) wherein R1, R2, R3 and R4 are, for example, Cl-C8alkyl, R5 is, for example, hydrogen, A is CI, Br, -0-R7, -NR8R9 or -S-R16, A' is -O-, -NH- or -NR8-, X and Y are each indepe...  
WO2004071434A3
The present invention is directed novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a mammal suffering from a disease where I...  
WO/2004/089873A1
Process for crystallising Bupropion hydrochloride comprising the following stages: a) Bupropion hydrochloride is dissolved in a mixture comprising methanol and a precipitating solvent for Bupropion hydrochloride; b) any insoluble residue...  
WO2004071401A3
A compound having the following formula (I): wherein R<1> is lower alkyl optionally substituted with one or more suitable substituent(s); aryl optionally substituted with one or more suitable substituent(s); or fused ring, R<2> is acylam...  
WO/2004/087061A2
A diverse set of tubulin binding agents have been discovered which are structurally characterized, in a general sense, by a semi-rigid molecular framework capable of maintaining aryl-aryl, pseudo pi stacking distances appropriate for mol...  
WO/2004/083336A2
The present invention provides functional finishing dyes comprising at least one functional finishing group covalently attached to a traditional dye via a chemical linkage. More particularly, the present invention provides novel antimicr...  
WO/2004/073642A2
The present invention provides a combinatorial approach to a library of novel compounds having four diversity points. The compounds provide for the mapping of urotensin II and somatostatin 5 receptors by differential binding of said rece...  
WO/2004/071434A2
The present invention is directed novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a mammal suffering from a disease where I...  
WO/2004/071401A2
A compound having the following formula (I): wherein R1 is lower alkyl optionally substituted with one or more suitable substituent(s); aryl optionally substituted with one or more suitable substituent(s); or fused ring, R2 is acylamino ...  
WO2004056365A3
A compound of formula (I): wherein R1, R2, R3 and Y are as defined herein, or a pharmaceutically-acceptable and -cleavable ester, or acid addition salt thereof, useful for promoting the release of parathyroid hormone, e.g. for preventing...  
WO2004056762A3
The invention provides novel compounds according to formula (I) relates to compounds with the general formula (I), said compounds being useful, e.g. in the treatment of inflammatory diseases.  
WO/2004/065401A1
This invention relates to a new class of polyene polyketides, their pharmaceutically acceptable salts and derivatives, and to methods for obtaining the compounds. One method of obtaining these compounds is by cultivation of novel strains...  
WO2004040534A3
beta-diketone fluorescent tags are disclosed, particularly those enabling the use of excitation energy in the near visible or visible spectrum. In some cases, these tags allow the use of cost-effective excitation devices such as LED's. T...  
WO2004014550A3
The invention relates to novel monocarbene complexes of nickel, palladium or platinum containing electron-deficient olefin ligands, to their production and to the use thereof in the homogeneous catalysis of organic reactions (Formula II ...  
WO/2004/058691A1
This disclosure describes antifungal antibiotics designated Hygroscopene A, Hygroscopene B and Hygroscopene C to their production by fermentation, to methods for recovery and concentration from the crude solutions, to a process for purif...  
WO/2004/056762A2
The invention provides novel compounds according to formula (I) relates to compounds with the general formula (I), said compounds being useful, e.g. in the treatment of inflammatory diseases.  
WO/2004/056365A2
A compound of formula (I): wherein R1, R2, R3 and Y are as defined herein, or a pharmaceutically-acceptable and -cleavable ester, or acid addition salt thereof, useful for promoting the release of parathyroid hormone, e.g. for preventing...  
WO/2004/054982A1
Disclosed are novel biphenylcarboxamides of formula (I), wherein R, Z, X, Y, m, n, and A have the meanings indicated in the description, several methods for producing said substances, the use thereof for controlling undesired microorgani...  
WO/2004/052359A1
Methods are disclosed for inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of lymphocytes (e.g., T-cells, B-cells). A Ma...  
WO/2004/043921A1
A novel, improved, and general process for the preparation of 4-aryl-3-hydroxymethyl-1-methylpiperidines is disclosed in the present invention. 4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine is a well-known intermediate in making ...  
WO2003086605A3
One aspect of the present invention relates to ionic liquids comprising a pendant Bronsted-acid group, e.g., a sulfonic acid group. Another aspect of the present invention relates to the use of an ionic liquid comprising a pendant Bronst...  
WO/2004/040534A2
β-diketone fluorescent tags are disclosed, particularly those enabling the use of excitation energy in the near visible or visible spectrum. In some cases, these tags allow the use of cost-effective excitation devices such as LED’s. T...  
WO2004013077A3
A compound of formula (I) or (II): wherein A is hydrogen or CR<1>R<2>; Y and Z are each, independently, hydrogen or a halogen; X is -NR<4>R<5>, or R<7>; R<1> is hydrogen, or a substituted or unsubstituted alkyl or alkenyl group containin...  
WO2003106399A3
The invention provides processes for preparing N-protected beta-amino aldehyde compounds which are useful as synthetic intermediates for preparing glycopeptide antibiotic derivatives. The processes include cleaving a carbon-carbon double...  
WO/2004/026804A1
The invention provides novel anthraquinone compositions that are useful as broad-spectrum quenchers of fluorescence and provides methods for making and using them. The anthraquinone quenchers can be conjugated to a variety of biologicall...  
WO/2004/026850A1
The present invention relates to processes for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles (5a) from cyclohexanes (2a) and cyclohexanones (3a) as intermediate.  
WO/2004/026817A1
An amino alcohol derivative represented by the general formula (1): (1) &lcub e.g., (±)-2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2- methylpentan-1-ol&rcub . It has excellent immunosuppressive activity and is reduced in side ...  
WO2003048106A3
The invention concerns 1,3-diarylprop-2-en-1-ones and derivatives, compositions containing same and the use thereof. The invention concerns in particular novel substituted 1,3-diarylprop-2-en-1-ones having a therapeutic activity for use ...  
WO/2004/024674A1
This invention is related to the preparation of bupropion hydrochloride. The reaction of 3'-chloropropiophenone with bromine in presence of tert-butylamine to prepare the bupropion free base and then recovering of bupropion hydrochloride...  
WO2003097576A3
The invention provides novel diamino-functionalised chalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infec...  
WO2003018535A3
The invention relates to a novel class of aminobenzophenones derivatives, to pharmaceutical preparations comprising said compounds, to dosage units of such preparations, to methods of treating patients comprising administering said compo...  
WO/2004/020391A1
The invention relates to monoalkylamino ketones of formula (I), wherein R1 and R2 have the meanings as cited in the description.  
WO2002057211A8
Symmetrically disubstituted aromatic compounds and pharmaceutical compositions containing such compounds that inhibit and/or modulate the activity of poly(ADP-ribose) glycohydrolase, also known as PARG, are described. The invention is al...  
WO2003097574A3
The invention provides novel alkoxyaminochalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is al...  

Matches 251 - 300 out of 3,207